Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Advanced Formulation Approaches for Targeted Drug Delivery"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 December 2019).
Interests: organic–inorganic hybrid nanocomposites; oral protein delivery; nanomedicine, targeted drug delivery
Interests: PEGylation; protein stability; nanomedicine; dendrimers; targeted drug delivery
Special Issues and Collections in MDPI journals
Targeted drug delivery is an approach for delivering therapeutics to a patient in a manner that accumulates drugs selectively in the site of action relative to others in the body. The advantages of targeted drug delivery are especially evident in cancer chemotherapy. The selective delivery of cytotoxic drugs to cancer cells allows high local drug concentrations in the target cells while minimizing toxicity to normal cells. Nanoparticles have been one of the main subjects in the area of targeted drug-delivery. Recent advances in nanotechnology facilitate the development of more elaborated targeted-delivery systems for various therapeutics via active targeting or passive targeting.
This Special Issue of Pharmaceutics focuses on new strategies and advanced formulation approaches for targeted drug-delivery including liposomes, polymeric nanoparticles, dendrimers, nanocomposites, and antibody drug conjugates. We welcome articles dealing with all aspects of targeted drug-delivery systems and invite researchers and drug developers to publish their original research or review articles with expert opinions and perspectives in the area of therapeutics.
Prof. Dr. Hyo-Kyung Han
Prof. Dr. Dong Hee Na
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- targeted drug delivery;
- antibody–drug conjugates;